Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study. Article Swipe
Related Concepts
Duchenne muscular dystrophy
Medicine
Muscular dystrophy
Enzyme replacement therapy
Internal medicine
Regimen
Muscle weakness
Clinical trial
Adverse effect
Clinical significance
Physical therapy
Gastroenterology
Disease
Kadalraja Raghavan
,
Thanasekar Sivakumar
,
Koji Ichiyama
,
Naoki Yamamoto
,
Balamurugan Mangaleswaran
,
Vidyasagar Devaprasad Dedeepiya
,
Rajappa Senthilkumar
,
Senthilkumar Preethy
,
Samuel JK Abraham
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.36185/2532-1900-312
· OA: W4394755263
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.36185/2532-1900-312
· OA: W4394755263
This study has proven the safety of Neu REFIX beta-glucan food supplement and its efficacy in improving both plasma biomarkers and functional parameters of muscle in a short duration of 2 months. Further validation by evaluation of muscle function for a longer duration is recommended to confirm the efficacy of Neu-REFIX food supplement as a potential adjuvant DMT in muscular dystrophies.
Related Topics
Finding more related topics…